Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C9H9NO |
| Molecular Weight | 147.1739 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1C(=O)NC2=C1C=CC=C2
InChI
InChIKey=BBZCPUCZKLTAJQ-UHFFFAOYSA-N
InChI=1S/C9H9NO/c1-6-7-4-2-3-5-8(7)10-9(6)11/h2-6H,1H3,(H,10,11)
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| The pneumotoxin 3-methylindole is a substrate and a mechanism-based inactivator of CYP2A13, a human cytochrome P450 enzyme preferentially expressed in the respiratory tract. | 2009-10 |
|
| Porcine CYP2A19, CYP2E1 and CYP1A2 forms are responsible for skatole biotransformation in the reconstituted system. | 2009 |
|
| Unbiased high-throughput screening of reactive metabolites on the linear ion trap mass spectrometer using polarity switch and mass tag triggered data-dependent acquisition. | 2008-08-15 |
|
| Palladium-catalyzed alpha-vinylation of carbonyl compounds. | 2007-10-11 |
|
| Metabolism and bioactivation of 3-methylindole by human liver microsomes. | 2007-01 |
|
| The role of CYP2A and CYP2E1 in the metabolism of 3-methylindole in primary cultured porcine hepatocytes. | 2006-05 |
|
| Phase II in vitro metabolism of 3-methylindole metabolites in porcine liver. | 2003-05 |
|
| Selective dehydrogenation/oxygenation of 3-methylindole by cytochrome p450 enzymes. | 2001-07 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
M6O509COF9
Created by
admin on Wed Apr 02 13:04:57 GMT 2025 , Edited by admin on Wed Apr 02 13:04:57 GMT 2025
|
PRIMARY | |||
|
1504-06-9
Created by
admin on Wed Apr 02 13:04:57 GMT 2025 , Edited by admin on Wed Apr 02 13:04:57 GMT 2025
|
PRIMARY | |||
|
17397
Created by
admin on Wed Apr 02 13:04:57 GMT 2025 , Edited by admin on Wed Apr 02 13:04:57 GMT 2025
|
PRIMARY | |||
|
DTXSID30933933
Created by
admin on Wed Apr 02 13:04:57 GMT 2025 , Edited by admin on Wed Apr 02 13:04:57 GMT 2025
|
PRIMARY | |||
|
150923
Created by
admin on Wed Apr 02 13:04:57 GMT 2025 , Edited by admin on Wed Apr 02 13:04:57 GMT 2025
|
PRIMARY | |||
|
51674-13-6
Created by
admin on Wed Apr 02 13:04:57 GMT 2025 , Edited by admin on Wed Apr 02 13:04:57 GMT 2025
|
ALTERNATIVE |
PARENT (METABOLITE)
SUBSTANCE RECORD
